【摘要】目的 分析注射用重组人尿激酶原(rhPro-UK)治疗急性ST段抬高型心肌梗死(STEMI)的效果。方法 选取我院收治的STEMI患者60例，将其分为2组，评定疗效，分析出血影响因素。结果 试验组治疗有效率为93.3%，高于对照组的73.3%；治疗后IL-6、hs-CRP、CK指标明显降低，且试验组指标优于对照组，差异显著(P<0.05)。Logistic回归分析显示，年龄>70岁、WBC≥4×109/L、Hb<110 g/L、Scr≥133 μmol/L是患者出血的影响因素。结论 rhPro-UK治疗STEMI疗效确切，不仅安全性高，而且能改善生化指标。

    【关键词】STEMI；rhPro-UK；不良反应；影响因素

    【中图分类号】R542.22 【文献标识码】B 【文章编号】ISSN.2095-6681.2017.36..02

    【Abstract】Objective To analyze the effect of Recombinant Human Prourokinase for Injection (rhPro-UK) in the treatment of acute ST segment elevation myocardial infarction (STEMI).Methods 60 cases of STEMI patients in our hospital were selected and divided into 2 groups. The clinical effect was evaluated and the influencing factors of bleeding were analyzed.Results The effective rate of the treatment group was 93.3% ......